• Search
  • Helpdesk
  • Sales contact

Client satisfaction at its best: Kayentis achieves 90%+ client recommendation rate 4 years in a row

Last updated: September 17, 2025

At Kayentis, we’re pleased to share the results of our latest client survey, conducted in January 2025. The feedback highlights how much our clients value our partnership, expertise, and dedication. From strong recommendation rates to positive feedback, the results reaffirm our ongoing commitment to delivering quality and excellence while building trust every day.

Client Recommendation Rate Above 90% – Four Years Running

We are proud to share that once again, over 90% of our clients said they would recommend us to a colleague or partner. This marks the fourth consecutive year we’ve surpassed this milestone, reflecting our consistent quality, dedication, and the strong relationships we maintain with our clients.
Clients praise the professionalism and adaptability of our teams:

Groupe 3104

“Kayentis team -from Business Developers, Operations team to other support teams- are very professional, flexible, and willing to cater to a customized solution for an eCOA need.
Not all suppliers who claimed they were willing to do so actually did.”

A Strong Net Promoter Score of +66

Our NPS score of +66, well above industry averages, highlights the confidence clients place in our work.
Clients highlight the depth of our expertise and knowledge:

Groupe 3104

“Kayentis is an ePRO/eCOA expert in the pharmaceutical industry and has knowledge, as well as organized and standardized specifications.”

Quality and Collaboration That Matter

Clients commend the quality of our deliverables and the flexible way we collaborate, which allows their clinical trials to progress seamlessly:

Groupe 3104

“Kayentis is forward-thinking about quality and how to deliver the best solution for the client.”

“Kayentis provides flexibility and the feeling of a true partnership to reach study success, vs. just a vendor-like relationship.”

Another key theme from the feedback is transparency, which our clients value highly in building trust and strong partnerships:

Groupe 3104

Kayentis will never over-promise and will therefore always deliver what they promise to deliver.

Looking Ahead

We are grateful to our clients for their feedback and ongoing partnership. As we move forward, our focus remains clear: delivering excellence, building trust, and creating value for every client we work with.

Meet us at the following events

ACDM 2026

MAR 15-17 2026 • Berlin, Germany
Booth #22 ACDM26 15-17 March 2026

C-PATH 2026

APR 16-17 2026 • Washington, D.C. USA

2026 Precision in Clinical Trials

APR 30 - MAY 1 2026 • Boston, MA, USA
Booth #3 Precision In Clinical Trials Summit | April 30 - May 1 - Boston

OCT Europe 2026

MAY 6-7 2026 • Barcelona, Spain
Booth #59 16th Annual Outsourcing in Clinical Trials Europe 2026 - Arena International

OCT East Coast 2026

MAY 12-13 2026 • New Brunswick, NJ, USA
Booth #7 17th Annual Outsourcing in Clinical Trials East Coast 2026 - Arena International

Patients as Partners 2026

MAY 19-20 2026 • London, UK
Patients as Partners EU

PCMG 2026

JUNE 16-17 2026 • Berlin, Germany
Register For PCMG26 Updates - PCMG 2026 Annual Assembly